Monash IVF Group Limited (FRA:MIS)

Market Cap	174.98M +13.1%
Revenue (ttm)	163.17M -0.9%
Net Income	4.50M -70.3%
EPS	0.01 -70.3%
Shares Out	n/a
PE Ratio	35.90
Forward PE	14.78
Dividend	0.02 (3.58%)
Ex-Dividend Date	Sep 3, 2026

Volume	2,550
Open	0.4280
Previous Close	0.4360
Day's Range	0.4280 - 0.4280
52-Week Range	0.3160 - 0.5250
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About Monash IVF Group

Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2014
• Employees: 892
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MIS

Financial Performance

In fiscal year 2026, Monash IVF Group's revenue was 269.46 million, a decrease of -0.90% compared to the previous year's 271.92 million. Earnings were 7.43 million, a decrease of -70.31%.

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error